Patent ID: 11890320
Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treating a bone trauma, disease or disorder treatable by enhancing bone formation, strength, volume, or density in a human subject, the method comprising:
administering a human C-type Lectin Domain Containing 11A (CLEC11a) to the subject, wherein the human CLEC11a comprises the sequence of SEQ ID NO: 10;
wherein the human CLEC11a is administered systemically or locally;
wherein if the human CLEC11a is administered locally, it is administered to a site of the bone in need of treatment; and
wherein the human subject suffers from a bone fracture, osteopenia, osteoporosis, periodontal disease, or is in need of a spinal fusion or a dental implant.